The better-than-expected Q3 results were driven by ongoing increased demand for COVID-19 solutions and improved trends in the non-COVID business. Robust sales growth and prudent cost management translated into a higher operating margin. With COVID cases on the rise and new products on the market, sales could accelerate in Q4. Thus, the FY20 guidance has been raised. Management has shortlisted five growth pillars for the post-pandemic world. More details at the upcoming investor day.
